ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Three Benefits Of Centralizing Global Content For eCOA Migration

  Now, more than ever, sponsors aim to empower the global patient voice through patient-centric technologies—including providing wearable technologies and using electronic clinical outcome assessments (eCOAs) to collect patient data.

• Top 5 Ways To Leverage eLogs In Clinical Research

  Unearth how embracing these specific approaches ensures that technology becomes a true ally in enhancing precision, accessibility, and collaboration within the intricate realm of clinical research.

• Digital Health Solution For CRS Detection And Prediction

  Explore how digital health technologies offer a data-driven solution to cytokine release syndrome (CRS) monitoring, reducing inpatient care requirements while ensuring patient safety.

• Navigating Wearable Integration: Key Operational Considerations

  Explore wearable devices' transformative potential and innovative capabilities for data collection, patient monitoring, and endpoint measurement.

• Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call

  Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

• Optimizing Prader-Willi Syndrome Clinical Trials

  Learn how Signant is helping to mitigate placebo responses and ensuring high-quality data to improve Prader-Willi syndrome (PWS) clinical trial success.

• Revolutionizing Clinical Trial Feasibility

  Transform feasibility into a continuous, data-driven process, that helps sponsors streamline trial planning, maintain timelines, and deliver therapies to patients faster.

• Helping Biotechs Overcome 4 Key Challenges

  Delays in site payments, participant reimbursements, and logistical inefficiencies can create roadblocks for patients and sites.

• Clinical Trial Governance A Strategic Look At KPIs From An RTSM Perspective

  Learn how data-driven metrics improve oversight, mitigate risk, and accelerate execution while safeguarding supply continuity and patient safety.

• Optimizing Wearable Adherence In A Phase 3 Oncology Trial

  Long-term wearable monitoring only works if patients keep wearing the device, and in oncology trials, that’s easier said than done.